Tocilizumab: A novel humanized anti-interleukin 6 (IL-6) receptor antibody for the treatment of patients with non-RA systemic, inflammatory rheumatic diseases

Author: Alten Rieke   Maleitzke Tazio  

Publisher: Informa Healthcare

ISSN: 0785-3890

Source: Annals of Medicine, Vol.45, Iss.4, 2013-06, pp. : 357-363

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content